Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Observational Program of Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorders (FRIENDS)

NCT02043197 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT02043197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02043197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Observational Program of Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorders (FRIENDS)
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
November 30, 2015
Enrollment
300 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

depression